Accepting new patients

Dr. Mitchell Kamrava, MD

Radiation Oncology ·  Male · Age 40

Dr. Kamrava

UCLA Radiation Oncology

200 UCLA MEDICAL PLZ STE B265 Los Angeles, CA 90095

Accepting new patients

Make an Appointment

(310) 825-9775


Dr. Mitchell Kamrava, MD is a radiation oncology specialist in Los Angeles, CA. He specializes in radiation oncology.


At a glance

  • Explains conditions well . Patients said this doctor explains conditions well. See reviews
  • Hospital satisfaction . Patients said they were highly satisfied at this doctor's hospital. See hospitals
  • Practices at top hospital . America's 100 Best Hospitals Award™ See hospitals

Insurance Check

Search for your insurance provider

Dr. Kamrava accepts

Accepted insurance can change. Please double-check when making an appointment.

(310) 825-9775

Dr. Kamrava accepts the following insurance:

Aetna
Aetna HMO
Choice Plus POS II
Blue Cross Blue Shield
Blue Card PPO
Blue Cross Blue Shield of California
Select Plus HMO
First Health (Coventry Health Care)
First Health (Coventry Health Care) PPO
MultiPlan
PHCS Network PPO

Background Check

No malpractice claims found for California
No disciplinary actions found for the years we collect data
No board actions found for the years we collect data
Learn more about background checks

Experience Check

Check Dr. Kamrava's experience treating your condition or procedure

Dr. Kamrava's Top Procedures and Conditions

Treatment Frequency
Gynecologic Cancer
very high
very high

Treatment Frequency

Dr. Kamrava treats Gynecologic Cancer more than 91% of his peers

Dr. Kamrava treats this condition more than 91% of his peers

Rating Includes other areas of care:

  • Cervical Cancer
  • Choriocarcinoma
  • Endometrial Cancer
  • Fallopian Tube Cancer
  • Glassy Cell Carcinoma
  • Ovarian Cancer
  • Ovarian Epithelial Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Vulvar Cancer
Cancer
high
high

Treatment Frequency

Dr. Kamrava treats Cancer more than 84% of his peers

Dr. Kamrava treats this condition more than 84% of his peers

Rating Includes other areas of care:

  • Adenoid Cystic Carcinoma
  • Adolescent Cancer
  • Adrenal Cortical Carcinoma
  • Adrenal Gland Cancer
  • Adult Cerebral Astrocytoma
  • Adult Small Cell Lung Cancer
  • Ampullary Carcinoma
  • Anal and Rectal Cancer
  • Anal Cancer
  • Anaplastic Oligodendroglioma
  • Angiosarcoma of the Breast
  • Appendix Cancer
  • Astrocytoma
  • Basal Cell Carcinoma (BCC)
  • Basal Type Breast Cancer
  • Benign Astrocytoma
  • Bile Duct Cancer
  • Biliary Cancer
  • Bladder Cancer
  • Blood Cancer
  • Bone Cancer
  • Brain and Nervous System Cancer (Includes: Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
  • Brain Cancer
  • Brainstem Glioma
  • Breast Cancer
  • Breast Cancer Recurrence
  • Bronchioalveolar Carcinoma
  • Bronchogenic Carcinoma
  • Cancer of Floor of Mouth
  • Cerebellar Astrocytoma
  • Cerebral Astrocytoma
  • Cervical Cancer
  • Cholangiocarcinoma
  • Chordoma
  • Choriocarcinoma
  • Chromophobe Renal Cell Carcinoma
  • Clear Cell Adenocarcinoma
  • Clear Cell Renal Cell Carcinoma
  • Colorectal Cancer
  • Cutaneous Squamous Cell Carcinoma
  • Distal Colorectal Cancer
  • Distal Gastrointestinal Tract Cancers
  • Ductal Carcinoma in Situ
  • Duodenal Cancer
  • Ear Cancer
  • Endocrine Cancer
  • Endometrial Cancer
  • ENT Cancer
  • Epidermoid Carcinoma
  • Epithelial-Myoepithelial Carcinoma
  • Esophageal Cancer
  • Extrahepatic Bile Duct Cancer
  • Eye Cancer
  • Facial Skin Cancer
  • Fallopian Tube Cancer
  • Familial Colorectal Cancer
  • Familial Pancreatic Cancer
  • Familial Renal Cancer
  • Familial Renal Cell Carcinoma
  • Fibrolamellar Hepatocellular Carcinoma
  • Follicular Adenocarcinoma
  • Follicular Thyroid Cancer
  • Gall Bladder Cancer
  • Gallbladder & Biliary Tract Cancer
  • Gastric Cancer, Borrmann 4
  • Gastroenterologic Cancer (Colon, Stomach, Esophageal, Liver)
  • Genital System Cancer
  • Genitourinary Cancers
  • Gland Cancer
  • Glassy Cell Carcinoma
  • Glioma
  • Gliomatosis Cerebri
  • Gynecologic Cancer
  • Hamartomatous Colorectal Cancer
  • Heart Cancer
  • Hepatobiliary Cancer
  • Hepatocellular Cancer
  • Hepatocellular Carcinoma
  • Hip Cancer
  • Hypopharyngeal Cancer
  • Inflammatory Breast Cancer
  • Infundibulocystic Basal Cell Carcinoma
  • Intestinal Cancer
  • Intrahepatic Cholangiocarcinoma
  • Invasive Breast Cancer
  • Invasive Ductal Carcinoma
  • Invasive Lobular Carcinoma
  • Joint Cancer
  • Juvenile Pilocytic Astrocytoma
  • Laryngeal Cancer
  • Laryngeal Carcinoma
  • Limb Cancer
  • Lip Cancer
  • Liver Cancer
  • Locally Advanced Breast Cancer
  • Lung Cancer
  • Lymphoma of the Breast
  • Male Breast Cancer
  • Male Genitourinary Cancer
  • Malignant Astrocytoma
  • Malignant Breast Tumor
  • Malignant Glioma
  • Mediastinal Cancer
  • Medullary Thyroid Cancer
  • Medulloblastoma
  • Melanoma-Astrocytoma Syndrome
  • Merkel Cell Cancer
  • Metastatic Adrenal Gland Cancer
  • Metastatic Blood Cancer
  • Metastatic Bone Cancer
  • Metastatic Breast Cancer
  • Metastatic Cancer
  • Metastatic Liver Cancer
  • Metastatic Lymph Cancer
  • Metastatic Nervous System Cancer
  • Metastatic Prostate Cancer
  • Metastatic Skin Cancer
  • Metastatic Soft Tissue Cancer
  • Metastatic Spinal Cord Cancer
  • Metastatic Squamous Neck Cancer With Occult Primary
  • MSI-H Colorectal Cancer
  • MSI-L Colorectal Cancer
  • MSS Colorectal Cancer
  • Muscle Cancer
  • Nasal Cavity Cancer
  • Nasopharyngeal Cancer
  • Neck Cancer
  • Nerve Cancer
  • Neuroendocrine Cancer
  • Nevoid Basal Cell Carcinoma Syndrome
  • Nodular Basal Cell Carcinoma
  • Noduloulcerative Basal Cell Carcinoma
  • Non-Melanoma Skin Cancer
  • Nonpolyposis Colorectal Cancer, Familial
  • Non-Small Cell Lung Cancer
  • Nose Cancer
  • Oligodendroglioma
  • Oral Cancer
  • Oral Squamous Cell Carcinoma
  • Oropharyngeal Cancer
  • Oropharyngeal Cancer, Adult
  • Osteosarcoma of the Breast
  • Ovarian Cancer
  • Ovarian Epithelial Cancer
  • Palate Cancer
  • Pancreatic Cancer
  • Pancreatic Islet Cell Cancer
  • Papillary Renal Cell Carcinoma
  • Papillary Thyroid Cancer
  • Paranasal Sinus Cancer
  • Parathyroid (Gland) Cancer
  • Parathyroid Carcinoma
  • Parotid Gland Cancer
  • Pediatric Cancer
  • Pelvic Cancer
  • Penile Cancer
  • Pharyngeal Cancer
  • Pigmented Basal Cell Carcinoma
  • Pleura Cancer
  • Pre-Invasive Breast Cancer
  • Primary Prostate Cancer
  • Prostate Cancer
  • Prostate Cancer - Hereditary - 1
  • Prostate Cancer - Hereditary - 10
  • Prostate Cancer - Hereditary - 11
  • Prostate Cancer - Hereditary - 14
  • Prostate Cancer - Hereditary - 2
  • Prostate Cancer - Hereditary - 3
  • Prostate Cancer - Hereditary - 4
  • Prostate Cancer - Hereditary - 5
  • Prostate Cancer - Hereditary - 6
  • Prostate Cancer - Hereditary - 7
  • Prostate Cancer - Hereditary - 8
  • Prostate Cancer - Hereditary - 9
  • Prostate Cancer - Hereditary - X-Linked 1
  • Prostate Cancer - Hereditary - X-Linked 2
  • Prostate Cancer - Hereditary -12
  • Prostate Cancer - Hereditary -13
  • Prostate Cancer - Hereditary -15
  • Radiation-Induced Angiosarcoma of the Breast
  • Rectal Cancer
  • Renal (Kidney) Cancer
  • Renal Cell Cancer
  • Respiratory System Cancer
  • Retinal Cancer
  • Salivary Gland Cancer
  • Sebaceous Gland Carcinoma
  • Secretory Breast Carcinoma
  • Sinonasal Undifferentiated Carcinoma
  • Sinus Cancer
  • Skin Cancer
  • Small Cell Lung Cancer
  • Spinal Cord Cancer
  • Spleen Cancer
  • Sporadic Colorectal Cancer
  • Squamous Cell Carcinoma
  • Squamous Cell Carcinoma of Conjunctiva
  • Squamous Cell Carcinoma of Head and Neck
  • Stomach and Small Intestine Cancer
  • Stomach Cancer
  • Stomach Cancer, Familial
  • Superficial Basal Cell Carcinoma
  • Supraglottic Laryngeal Cancer
  • Testicular Cancer
  • Thoracic Cancer
  • Throat Cancer
  • Thymus Cancer
  • Thyroid Cancer
  • Thyroid Cancer, Anaplastic
  • Thyroid Cancer, Familial Medullary
  • Thyroid Cancer, Hurthle Cell
  • Tongue Cancer
  • Trachea Cancer
  • Transitional Cell Cancer
  • Transitional Cell Carcinoma
  • Tubular Carcinoma
  • Urachal Cancer
  • Ureteral Cancer
  • Urinary Tract Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Visual Pathway and Hypothalamic Glioma
  • Vocal Cord Carcinoma
  • Vulvar Cancer

Dr. Kamrava's conditions and procedures:

  • Cancer
  • Gynecologic Cancer
  • Vulvar Cancer

Dr. Kamrava's Reviews

Likelihood to recommend Dr. Kamrava

4.7

Based on 3 reviews

5 Stars
66.66666666666667%
(2)
4 Stars
33.333333333333336%
(1)
3 Stars
0%
(0)
2 Stars
0%
(0)
1 Star
0%
(0)

Leave a review

How likely are you to recommend
Dr. Kamrava?
(Select your rating)
Average Reported Wait Time
  • 16 – 30 minutes
Dr. Kamrava's Performance
  • Trustworthiness
  • Explains condition(s) well
  • Answers questions
  • Time well spent
Office & Staff Performance
  • Scheduling
  • Office environment
  • Staff friendliness
What People Say About Dr. Mitchell Kamrava, MD
RecentHighestLowestMost Helpful
Reply
Been having A LOT of meetings with specialists in Los Angeles since my recent diagnosis of prostate cancer. Dr. Kamrava has impressed me the most. Friendly and compassionate, patient and thorough, very articulate and knowledgable, a straight shooter, did not try to "sell me" on what he offered. Even though it was Friday afternoon and I could tell he was struggling with a cold, he was beyond generous with his time and energy. If I end up going with Brachytherapy, I wouldn't go to anyone else
Was this helpful?
thumbs up icon option2
thumbs down icon option
×Post a ResponseAre you Dr. Mitchell Kamrava, MD?
Reply
Excellent Doctor. Gentle, kind and soft spoken and was always available if I had questions or needed anything. Over and over I heard from doctor's, nurses, etc. that Dr. Kamrava was the absolute best in his field and I can attest to that! I am so grateful and feel so blessed to have had him and his amazing team at UCLA spearhead my treatment and full recovery.
Was this helpful?
thumbs up icon option2
thumbs down icon option
×Post a ResponseAre you Dr. Mitchell Kamrava, MD?
Reply
Dr Kamrava is a great doctor. He is a good listener and has a very gentle beside manor. I have always appreciated that he takes the time to explain things and if I am at the clinic and I have an issue he will normally try to come in to see me. Unfortunately he is very busy so trying to get a hold of him is sometimes hard. But overall I am very happy with my treatments with him.
Was this helpful?
thumbs up icon option3
thumbs down icon option
×Post a ResponseAre you Dr. Mitchell Kamrava, MD?

Leave a review

How was your experience with Dr. Kamrava?

About Me

Biography

Dr. Mitchell Kamrava, MD is a radiation oncology specialist in Los Angeles, CA. He specializes in radiation oncology.

Specialties

  • Radiation Oncology

Board Certifications

Awards

Affiliated Hospitals

Check the quality of care at hospitals where Dr. Kamrava treats patients.

Learn more

81% Patient experience rating, 12% higher than the national average

  • America's 250 Best Hospitals Award™ (2019, 2018, 2017)
  • America's 50 Best Hospitals Award™ (2019, 2018, 2017)

81% Patient experience rating, 12% higher than the national average

  • America's 100 Best Hospitals Award™ (2019)
  • America's 250 Best Hospitals Award™ (2019, 2018, 2017)
  • Outstanding Patient Experience Award™ (2019, 2018)